Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Paul B. Savage is active.

Publication


Featured researches published by Paul B. Savage.


Nature Immunology | 2002

Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail–truncated CD1d

Ya-Hui Chiu; Se Ho Park; Kamel Benlagha; Claire Forestier; Jayanthi Jayawardena-Wolf; Paul B. Savage; Luc Teyton; Albert Bendelac

For members of the CD1 family of β2-microglobulin–associated lipid-presenting molecules, tyrosine-based motifs in the cytoplasmic tail and invariant chain (Ii) govern glycoprotein trafficking through endosomal compartments. Little is known about the intracellular pathways of CD1 trafficking and antigen presentation. However, in vitro studies with cells transfected with mutant CD1 that had a truncated cytoplasmic tail have suggested a role for these tyrosine motifs in some, but not all, antigenic systems. By introducing a deletion of the tyrosine motif into the germ line, and through homologous recombination in embryonic stem cells, we now describe knock-in mice with the CD1d cytoplasmic tail deleted. Despite adequate surface CD1d expression and the presence of Ii, these mutant mice showed multiple and selective abnormalities in intracellular trafficking, antigen presentation and T cell development, demonstrating the critical functions of the CD1d cytoplasmic tail motif in vivo.


Archive | 2013

Mice Lacking Niemann-Pick Type C1 Protein Trafficking and NKT Cell Development in Cutting Edge: Impaired Glycosphingolipid

Albert Bendelac; Randi Stern; Dapeng Zhou; Paul B. Savage; Yuval Sagiv; Kelly Hudspeth; Jochen Mattner


Archive | 2010

'BUUZBDJEBNJEFIZESPMBTFTIBQFT/,5DFMM SFTQPOTFTCZJOGMVFODJOHUIFTFSVNUSBOTQPSU PGMJQJEBOUJHFOJONJDF

Stefan Freigang; Victoria Zadorozhny; Michele K. McKinney; Philippe Krebs; Rana Herro; Joanna Pawlak; Lisa Kain; Nicolas Schrantz; Kim Masuda; Yang Liu; Paul B. Savage; Albert Bendelac; Benjamin F. Cravatt; Luc Teyton


Archive | 2007

Compositions comprising nkt cell agonist compounds and methods of use

Luc Teyton; Albert Bendelac; Paul B. Savage


Archive | 2007

Galactosilceramida modificada para el tratamiento de enfermedades cancerosas

Paul B. Savage; Luc Teyton; Albert Bendelac


Archive | 2007

Hilfsstoffe und verwendungsverfahren

Luc Teyton; Albert Bendelac; Paul B. Savage


Archive | 2007

Modifizierte galactosyl-ceramide zum anfärben und stimulieren von natürlichen killer-t-zellen

Albert Bendelac; Paul B. Savage; Luc Teyton


Archive | 2007

Modifiziertes galactosyl-ceramid zur behandlung von krebsartigen erkrankungen

Paul B. Savage; Luc Teyton; Albert Bendelac


Archive | 2006

Activation de glycolipides bacteriens de cellules nkt appauvries en cd1d

Luc Teyton; Albert Bendelac; Paul B. Savage


Archive | 2006

Activación por glucolípidos bacterianos de linfocitos NKT restringidos por CD1d

Luc Teyton; Albert Bendelac; Paul B. Savage

Collaboration


Dive into the Paul B. Savage's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Luc Teyton

Brigham Young University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Joanna Pawlak

Scripps Research Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kim Masuda

Scripps Research Institute

View shared research outputs
Top Co-Authors

Avatar

Lisa Kain

Scripps Research Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nicolas Schrantz

Scripps Research Institute

View shared research outputs
Researchain Logo
Decentralizing Knowledge